Big Tobacco is privately funding research into the impact cannabis has on certain metabolic disorders – think Type II diabetes here – through its Disease Research program and the University of California Riverside.
$744K in funding will allow for research on the metabolic homeostasis of glucose on health. Researchers have theorized that the endocannabinoid system has a far greater impact on regulating metabolic processes than previously believed.
What do you think the research will show? What impact do you think the UC Riverside research might have on the developing cannabis industry?
Here’s a link to an article about this study from UCR: